Back to today’s briefing

Story perspectives

Cell and Gene Therapy Market to Skyrocket to $128.8B

4/25/2025

26 5

Summary

Story summary

The Cell and Gene Therapy market is set to soar from USD 20.5 billion in 2024 to an astounding USD 128.8 billion by 2035, fueled by an impressive 18.2% annual growth rate. This surge is driven by the increasing prevalence of chronic diseases, a wave of FDA approvals, and groundbreaking gene-editing innovations, with North America at the forefront of over 1,000 clinical trials worldwide.

1 of 1

Story summary

The Cell and Gene Therapy market is set to soar from USD 20.5 billion in 2024 to an astounding USD 128.8 billion by 2035, fueled by an impressive 18.2% annual growth rate. This surge is driven by the increasing prevalence of chronic diseases, a wave of FDA approvals, and groundbreaking gene-editing innovations, with North America at the forefront of over 1,000 clinical trials worldwide.